After Hours
$
1.36
Change
+0.01 +0.74%
Volume
Volume 7,884
Mar 24, 2023, 7:56 p.m.
Quotes are delayed by 20 min
Previous close
$ 1.30
$ 1.35
Change
+0.05 +3.85%
Day low
Day high
$1.26
$1.38

52 week low
52 week high
$1.10
$4.72

Market cap
$96.96M
Average volume
633,766
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-1.47
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on GMDA
-
Gamida Cell started at buy with $11 stock price target at Alliance Global
- Tomi Kilgore
-
Gamida Cell started at outperform with $15 stock price target at Oppenheimer
- Tomi Kilgore
Other News on GMDA
-
Gamida Cell (GMDA) Investor Presentation - Slideshow
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Gamida Cell Ltd. (GMDA)Q3 2022 Earnings Call Transcript
- Seeking Alpha
-
Gamida Cell GAAP EPS of -$0.29 beats by $0.02
- Seeking Alpha
-
Notable earnings before Monday's open
- Seeking Alpha
-
Athersys: Is Big Pharma Sleeping At The Wheel?
- Seeking Alpha
-
Gamida Cell gains on long-term data for blood cancer therapy
- Seeking Alpha
-
Gamida Cell shares slide on pricing ~$20M stock offering
- Seeking Alpha
-
Gamida Cell shares slide after stock offering
- Seeking Alpha
-
Gamida appoints Emergent’s former head of vaccines as new CEO
- Seeking Alpha
-
Gamida Cell: Gearing Up For FDA Approval
- Seeking Alpha
-
Gamida Cell Ltd. (GMDA) Q2 2022 Earnings Call Transcript
- Motley Fool
-
- Edgar Online - (EDG = 10Q, 10K)
-
Gamida Cell GAAP EPS of -$0.31 misses by $0.02
- Seeking Alpha
- Loading more headlines...
Press Releases on GMDA
-
Gamida Cell Announces Changes to Board of Directors
- BusinessWire - BZX
-
Gamida Cell Announces Closing of $25 Million Financing With Highbridge
- BusinessWire - BZX
-
Gamida Cell Provides Regulatory Update on Omidubicel
- BusinessWire - BZX
-
Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update
- BusinessWire - BZX
-
Gamida Cell to Present Corporate Highlights at 2022 Cell & Gene Meeting on the Mesa
- BusinessWire - BZX
-
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com